Novo Nordisk stock will ride a wave of demand for Ozempic pills in 2026.

There might be massive upside ahead for these drugmakers.

Milestone Pharmaceuticals (MIST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near ...

Citi launched broad coverage of major European pharmaceutical companies with a mixed outlook, issuing Buy ratings on AstraZeneca and Novartis while taking a more cautious stance on GSK, Novo Nordisk ...

Investing.com -- Citi has initiated coverage of the “Big 6” European pharmaceutical groups with a positive sector view, rating AstraZeneca (LON:AZN), Novartis AG (SIX:NOVN) and Roche (SIX:ROG) at Buy ...

The steep fall came amid concerns over delayed semaglutide approvals in Canada, which impacted the company's revenues during ...

In Q3, the company's net loss widened to ₹88.7 crore, as compared to ₹68.8 crore, year-on-year (Y-o-Y). Its revenue from ...

Investors in ANI Pharmaceuticals, Inc. ANIP need to pay close attention to the stock based on moves in the options market ...

Stock market today: Experts have recommended eight stocks to buy or sell on Wednesday — Axis Bank, APL Apollo, ICICI Bank, ...

Fulgent Genetics' diagnostics business is growing, with 15.4% revenue growth YTD and all segments contributing. Read why I ...

The future looks bright for this high-flying biotech stock.

Clorox tops our list of the best dividend aristocrats to buy. Morningstar director Erin Lash expects mid-single-digit ...